Syndecan-1 expression has prognostic significance in head and neck carcinoma
about
Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecanThe expression of syndecan-1 is related to the risk of endometrial hyperplasia progressing to endometrial carcinomaSyndecans in tumor cell adhesion and signalingSyndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and PrognosticationMolecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicineInsidious changes in stromal matrix fuel cancer progressionCleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer.CD138 (Syndecan-1) in thymic tumors: correlation with various World Health Organization types and clinical outcome.Endogenous synthesis of n-3 polyunsaturated fatty acids in Fat-1 mice is associated with increased mammary gland and liver syndecan-1.Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancerOmega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathwayProteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.MiR-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate ChainsPrognostic impact of syndecan-1 expression in invasive ductal breast carcinomas.Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells.Molecular functions of syndecan-1 in disease.Proteoglycans in prostate cancer.Molecular markers of cell adhesion in ameloblastomas. An update.The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumorsSyndecans as modulators and potential pharmacological targets in cancer progression.Syndecan-1 knockdown in endometrial epithelial cells alters their apoptotic protein profile and enhances the inducibility of apoptosis.Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma.In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids.Reduced serum levels of syndecan-1 in patients with tongue squamous cell carcinoma.Identification of an invasion regulatory domain within the core protein of syndecan-1.Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours.Altered expression of syndecan-1 in prostate cancer.Effects of syndecan-1 on the expression of syntenin and the migration of U251 glioma cells.Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil.Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells.Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy.Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas.Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
P2860
Q24290125-01FC8D08-A5FA-4F9B-876A-CBC77503B578Q24603990-25CBC144-433D-4B97-A6E3-5B2CD99D8A30Q24807364-622331AF-E4C2-41DC-8F4F-56D8D326EF2EQ26784262-85C55AAF-772B-4D5F-B8FE-60BE7E9326DEQ26796247-66A063FF-4216-47D1-B26A-41B882D70F78Q26851261-2A164168-FF68-4E0E-A519-7B7917ECB212Q33188043-1E50C8D6-B619-4B27-88E8-70ACE38C0146Q33219573-9D355085-D8F4-42BA-B554-18726F7C5277Q33719174-65F19490-9393-47BF-B23A-BA239D4E36ADQ33927026-68584C7A-2714-4776-BDCE-874F78432F4AQ35093807-C418969B-B63B-439F-BE66-C1CA59312BD3Q35230305-BD63A8CD-5237-4C5A-BE97-D5AA57FF3023Q35599740-A0FCE90E-7420-46AA-8C5C-AD110401907CQ35853982-34FA4BFD-0E2A-4513-BCC9-047A7896A02FQ35933767-CF462A39-15D6-4CFF-8A34-FB809C4E4ACDQ36740664-D2911C56-9B28-4A67-AB31-E6FB538A4EDFQ36940157-EA49858E-1BB1-4CBB-86A5-6149BE0D84EBQ37950202-CF8FE1B0-FD88-4670-9F6C-A3A3830285AAQ37986399-257C5062-6C6D-4198-B3B6-017D062DB544Q38132345-0968E9E4-C7C9-4F1A-80B9-9D895AC1FB7BQ38176008-52BAEA15-EE9C-41F5-82AF-FEBA3889B7C6Q38189392-228E3976-596F-44AD-96E3-642E3B863D69Q38309339-257B1F19-0BFE-49DB-9EA2-88DB6D83FE13Q38437960-BDD9D808-7C9F-4BA7-94CF-B02A58C8EEF7Q39599906-F0FC0557-7999-4A14-B641-20AF36CC98DAQ40211948-E2CDC774-8D09-4958-A24A-B1500D61D2AEQ40488299-4BD43B30-2176-4B18-AB3E-0B8B58F521F4Q41444734-045DD143-3133-41FD-B797-4F9EF40F5BAAQ42830140-2B9CFCF2-C615-4073-A8FF-1F3F05EC4E66Q47855156-638EDFDF-75F6-42A0-9F8E-A0DDBE910488Q50883313-45FCCCCF-BD5B-45B7-9CE2-484593CBE097Q53334967-F248C014-1C10-4CE7-9810-74FB8A34BE86Q53390700-3A39F321-4F4E-4008-A9E9-17E9261FC76BQ54559186-7A448D91-3800-423D-B24C-17199A82FD49Q55268597-B8279E7F-4E91-414A-9173-4DB9964F3FBEQ55304328-37C488DE-35EA-458A-A369-779F89909C74Q55507840-8344656F-E28C-47B5-9CF3-8FA9B0A74E5F
P2860
Syndecan-1 expression has prognostic significance in head and neck carcinoma
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@ast
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@en
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@nl
type
label
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@ast
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@en
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@nl
prefLabel
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@ast
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@en
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@nl
P2093
P2860
P356
P1476
Syndecan-1 expression has prognostic significance in head and neck carcinoma
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690088
P407
P577
1999-02-01T00:00:00Z
P5875
P6179
1020844710